Home > Income Statement > SYNCOM FORMULATIONS (INDIA)

SYNCOM FORMULATIONS (INDIA)
Operating Profit

    Back to Income Statement
SYNCOM FORMULATIONS (INDIA) is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for SYNCOM FORMULATIONS (INDIA)
Please provide your vote to see the results

SYNCOM FORMULATIONS (INDIA) Last 5 Year Operating Profit History

[Consolidated]

Mar2024Mar2023Mar2022Mar2017Mar2016
Operating Profit (Excl OI) ₹30 Cr₹20 Cr₹20 Cr₹17 Cr₹17 Cr

What is the latest Operating Profit of SYNCOM FORMULATIONS (INDIA) ?

The latest Operating Profit ratio of SYNCOM FORMULATIONS (INDIA) is ₹30 Cr based on Mar2024 Consolidated results.
Year Operating Profit
Mar2024₹30 Cr
Mar2023₹20 Cr
Mar2022₹20 Cr
Mar2017₹17 Cr
Mar2016₹17 Cr

How is Operating Profit of SYNCOM FORMULATIONS (INDIA) Trending?

Years Operating Profit % Change
Mar2024 ₹30 Cr
50.22
Mar2023 ₹20 Cr
-0.67
Mar2022 ₹20 Cr
21.04
Mar2017 ₹17 Cr
-0.70
Mar2016 ₹17 Cr -

Compare Operating Profit of peers of SYNCOM FORMULATIONS (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA) ₹1,817.0 Cr -11.5% -2.2% 59.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹395,326.0 Cr -2.3% -3.5% 9.2% Stock Analytics
DIVIS LABORATORIES ₹173,562.0 Cr -2.8% 1.3% 42.3% Stock Analytics
CIPLA ₹121,023.0 Cr -0.3% 3% -2.6% Stock Analytics
DR REDDYS LABORATORIES ₹109,558.0 Cr -3.7% 7.2% 8.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹109,204.0 Cr -1% -0.5% 13.2% Stock Analytics


SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA)

-11.5%

-2.2%

59.4%

SENSEX

-1.3%

-0.8%

6.3%


You may also like the below Video Courses